Journal Information
Vol. 37. Num. 7.July 2018
Pages 549-636
Download PDF
More article options
Vol. 37. Num. 7.July 2018
Pages 549-636
Letter to the Editor
DOI: 10.1016/j.repc.2017.11.012
Open Access
Residual shunt due to spontaneous perforation of polyvinyl alcohol membrane of ASD Occluder; what about after diagnosis?
Shunt residual devido a perfuração espontânea da membrana de álcool polivinílico de um dispositivo de encerramento de CIA. O que sucede após o diagnóstico?
Serdar Bozyelça,
Corresponding author

Corresponding author.
, Tayfun Sahinb
a University of Health Sciences, Derince Training and Research Hospital, Department of Cardiology, Kocaeli, Turkey
b Kocaeli University School of Medicine, Department of Cardiology, Kocaeli, Turkey
Related content
Rev Port Cardiol 2017;36:475.e1-310.1016/j.repc.2016.09.020
Sílvia Aguiar Rosa, Filipa Ferreira, Lídia de Sousa, António Fiarresga, José Diogo Martins, Ana Galrinho, Ana Agapito, Paula Fazendas, Fátima F. Pinto, Rui Cruz Ferreira
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Dear Editor,
Full Text

We read the article “Successful percutaneous closure of a residual atrial septal defect due to device failure” written by S. Aguiar Rosa et al.1 with great interest. We congratulate the authors for nice three-dimensional echocardiographic images and successful management of the device failure. We also used the CARDIA Ultrasept™ ASD device in 9 patients in our center and three of them became defective after 19 to 25 months, causing significant shunts through the device frame and requiring repeat procedures. We recently reported a patient with a massive shunt due to spontaneous perforation of an Ultrasept™ Occluder polyvinyl alcohol (PVA) membrane.2 Based on our experience and the many cases reported with different versions of the Ultrasept™ prostheses, and considering the possibility of unnoticed and unreported failures, we would like to point out that we do not completely agree with the statement, “Although the use of this material (PVA membrane) in ASD closure devices is generally successful…”, in the discussion section.

The treatment options are surgical removal of the failing device and repair with a patch and covering of the damaged membrane with a second device.3 The authors chose the second option and occluded the defect successfully with a 20-mm Ultrasept™ PFO device. We would also like to mention a few issues about the “device-in-device technique” preferred by the authors. Nobody, either previous authors, including ourselves, or the manufacturer, has been able to explain the mechanism of PVA membrane disappearance.2 Moreover, to our knowledge, Ultrasept™ PFO devices are also covered with a PVA membrane. Surgical repair might therefore be preferable because of the uncertain mechanism of the malfunction. In view of the many risks involved in open heart surgery and taking patient preference into account, the second-device technique can obviously be used. However, a device with a different structure should be chosen to avoid possible recurrence of inadequate endothelialization.

Conflicts of interest

The authors have no conflicts of interest to declare.

S.A. Rosa, F. Ferreira, L. Sousa
Successful percutaneous closure of a residual atrial septal defect due to device failure
Rev Port Cardiol, 36 (2017),
S. Bozyel, T. Sahin, E. Dervise
A massive left-to-right shunt due to delayed spontaneous perforation of polyvinyl alcohol membrane of atrial septal occluder
Arch Turk Soc Cardiol, 45 (2017), pp. 541-544
F. Chamié, M. Julio, C.G. a Luiz
Device-in-device: a transcatheter alternative to surgical explantation of a failing atrial septal defect intracardiac prosthesis
Catheter Cardiovasc Interv, 88 (2016), pp. 239-243
Copyright © 2018. Sociedade Portuguesa de Cardiologia
Revista Portuguesa de Cardiologia (English edition)

Subscribe to our Newsletter

Article options
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos